Browsing: after

Date: October 19, 2026searchers discovered that recurring arthritis triggered by cancer immunotherapy may be driven by immune cells that remember previous attacks and return in a more aggressive state. The findings could pave the way for treatments that prevent painful flare-ups while preserving the immune system’s ability to fight cancer. Share: FULL STORY

Date: October 10, 2026 Source: University College London Summary: A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received pembrolizumab for up to nine weeks before surgery instead…